Interested in participating in Synthego's mRNA Pilot Validation Program?
Qualified participants will receive access to RUO mRNA versions of AccuBase CBE, eSpOT-ON, and hfCas12Max generated using the same manufacturing platform and process foundation used across Synthego's GMP CRISPR editor services.
Participation includes access to Synthego scientists, insight into our manufacturing approach, and the opportunity to evaluate next-generation mRNA editors within your workflow.
Participation is limited and subject to qualification.
Selective Early Access to Synthego mRNA CRISPR Editors. Learn how Synthego's mRNA Pilot Validation Program gives researchers early access to next-generation CRISPR editors while providing insight into the manufacturing platform...
If you are working in infectious disease diagnostics, you are probably facing a familiar challenge: how do you achieve results that are fast, accurate, and accessible without compromising on any...
CRISPR diagnostics are transforming disease detection—making it faster, more flexible, and more accessible. Learn how this technology works and how you can apply it to your diagnostic development.
Cart
Account
Your Orders
Sign In